Clinical Trials Browser

Phase 3 × Lung Neoplasms × Gefitinib × Clear all

NCT01405079 2020-02-18

ADJUVANT

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

Lung Neoplasms, Neoplasms

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Phase 3 Completed

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT00357734 2016-08-30

Iressa Follow-up Trial

Phase 3 Completed

14 enrolled 10 charts

Breast Neoplasms, Lung Neoplasms

NCT02518802 2015-08-10

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

Phase 3 Unknown

Lung Neoplasms

NCT00006048 2013-12-19

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006049 2013-12-19

ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00955695 2013-08-02

Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer

Phase 3 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00091156 2012-07-16

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 3 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

Adenocarcinoma, Lung Neoplasms

NCT00144066 2005-09-02

A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Phase 3 Completed

Lung Neoplasms